WallStSmart
VANI

Vivani Medical Inc.

NASDAQ: VANI · HEALTHCARE · BIOTECHNOLOGY

$1.34
+1.52% today

Updated 2026-04-30

Market cap
$115.97M
P/E ratio
P/S ratio
EPS (TTM)
$-0.43
Dividend yield
52W range
$1 – $2
Volume
0.3M

WallStSmart proprietary scores

16
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
5.0
Quality
C+
3.0
Profitability
D
5.0
Valuation
C+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$4.83
+260.67%
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

X-Ray snapshot

Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-6.99M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-13.89M$-25.65M$-23.49M$-26.61M$-6.63M
EPS$-0.43
Free cash flow$-19.13M$-24.59M$-21.34M$-25.49M$-6.99M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
VANI$115.97M164.33.05.05.0Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Vivani Medical Inc. trades at $1.34. Our Smart Value Score of 16/100 indicates the stock is weak.

Frequently asked questions

What is Vivani Medical Inc.'s stock price?
Vivani Medical Inc. (VANI) trades at $1.34.
Is Vivani Medical Inc. overvalued?
Smart Value Score 16/100 (Grade F, Strong Sell).
What is the price target of Vivani Medical Inc. (VANI)?
The analyst target price is $4.83, representing +260.7% upside from the current price of $1.34.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-159.60%
Beta3.37
50D MA$1.19
200D MA$1.34
Shares out0.08B
Float0.04B
Short ratio
Avg volume0.3M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years